MiR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression

Cancer Letters

Volumn 344, Issue 1, 2014, Pages 40-46

  Guo, Shixiang ^a   Xu, Xuejun ^a   Tang, Yichen ^a   Zhang, Chaobin ^a   Li, Jian ^a   Ouyang, Yongsheng ^a   Ju, Jingfang ^b   Bie, Ping ^a   Wang, Huaizhi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Bmi 1; EMT; MiR 15a; Pancreatic ductal adenocarcinoma; Proliferation

Indexed keywords

BMI1 PROTEIN; MICRORNA 15A; UVOMORULIN;

ADULT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION;

MOLONEY MURINE LEUKEMIA VIRUS;

BMI-1; EMT; MIR-15A; PANCREATIC DUCTAL ADENOCARCINOMA; PROLIFERATION;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYCOMB REPRESSIVE COMPLEX 1; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84893694761     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.10.009     Document Type: Article

References (36)

1. O'Sullivan A.W., Heaton N., Rela M. Cancer of the uncinate process of the pancreas: surgical anatomy and clinicopathological features. Hepatobiliary Pancreat Dis. Int. 2009, 8(6):569-574.
2. Michaud D.S. Epidemiology of pancreatic cancer. Minerva Chir. 2004, 59(2):99-111.
3. Wang L., Yang G.H., Lu X.H., Huang Z.J., Li H. Pancreatic cancer mortality in China (1991-2000). World J. Gastroenterol. 2003, 9:1819-1823.
4. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2003, 53(1):5-26.
5. Li X., Abdel-Mageed A.B., Mondal D., Kandil E. MicroRNA expression profiles in differentiated thyroid cancer, a review. Int. J. Clin. Exp. Med. 2013, 6(1):74-80.
6. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 2007, 120:1046-1054.
7. Song B., Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev. Mol. Med. 2010, 12:e33.
8. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(39):13944-13949.
9. Karaayvaz M., Pal T., Song B., Zhang C., Georgakopoulos P., Mehmood S., Burke S., Shroyer K., Ju J. Prognostic significance of miR-215 in colon cancer. Clin. Colorectal Cancer 2011, 10(4):340-347.
10. Tang J., Ahmad A., Sarkar F.H. The role of MicroRNAs in breast cancer migration, invasion and metastasis. Int. J. Mol. Sci. 2012, 13(10):13414-13437.
11. Das Nabajit MicroRNA targets - how to predictα. Bioinformation 2012, 8(17):841-845.
12. Tran N., McLean T., Zhang X., Zhao C.J., Thomson J.M., O'Brien C., Rose B MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun. 2007, 358:12-17.
13. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
14. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., SweetCordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838.
15. Rosenfeld N., Aharonov R., Meiri E., Rosenwald S., Spector Y., Zepeniuk M., et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 2008, 26(4):462-469.
16. Zhang X.J., Ye H., Zeng C.W., He B., Zhang H., Chen Y.Q. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J. Hematol. Oncol. 2010, 3:46.
17. Engelsen I.B., Mannelqvist M., Stefansson I.M., Carter S.L., Beroukhim R., Øyan A.M., Otte A.P., Kalland K.H., Akslen L.A., Salvesen H.B. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. Br. J. Cancer 2008, 98(10):1662-1669.
18. Bhattacharya R., Nicoloso M., Arvizo R., Wang E., Cortez A., Rossi S., Calin G.A., Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009, 69(23):9090-9095.
19. Yang G.F., He W.P., Cai M.Y., He L.R., Luo J.H., Deng H.X., Guan X.Y., Zeng M.S., Zeng Y.X., Xie D. Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC Cancer 2010, 10:133.
20. Zhai H., Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front. Genet. 2011, 2:78.
21. Guo B.H., Feng Y., Zhang R., Xu L.H., Li M.Z., Kung H.F., Song L.B., Zeng M.S. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol. Cancer 2011, 10:10.
22. Glinsky G.V., Berezovska O., Glinskii A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 2005, 115(6):1503-1521.
23. Song W., Tao K., Li H., Jin C., Song Z., Li J., Shi H., Li X., Dang Z., Dou K. Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci. 2010, 101(7):1754-1760.
24. Dong P., Kaneuchi M., Watari H., Hamada J., Sudo S., Ju J., Sakuragi N. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol. Cancer 2011, 10:99.
25. Cano C.E., Motoo Y., Iovanna J.L. Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma. Sci. World J. 2010, 10:1947-1957.
26. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.G., Bhatt D., Taccioli C., Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297(17):1901-1908.
27. Dai L., Wang W., Zhang S., Jiang Q., Wang R., Dai L., Cheng L., Yang Y., Wei Y.Q., Deng H.X. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo. Cell Biol. Int. 2012, 36(8):765-770.
28. Li J., Wei H., Li Y., Li Q., Li N. Identification of a suitable endogenous control gene in porcine blastocysts for use in quantitative PCR analysis of microRNAs. Sci. China Life Sci. 2012, 55(2):126-131.
29. Hamada S., Satoh K., Masamune A., Shimosegawa T. Regulators of epithelial mesenchymal transition in pancreatic cancer. Front. Physiol. 2012, 3:254.
30. Davidson B., Tropé C.G., Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Front. Oncol. 2012, 2:33.
31. Lee M.Y., Shen M.R. Epithelial-mesenchymal transition in cervical carcinoma. Am. J. Transl. Res. 2012, 4(1):1-13.
32. Sreekumar R., Sayan B.S., Mirnezami A.H., Sayan A.E. MicroRNA control of invasion and metastasis pathways. Front. Genet. 2011, 2:58.
33. Dave B., Mittal V., Tan N.M., Chang J.C. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res. 2012, 14(1):202.
34. Zlobec I., Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010, 1(7):651-661.
35. Aqeilan R.I., Calin G.A., Croce C.M. MiR-15a and miR-16-1 in cancer discovery, function and future perspectives. Cell Death Differ. 2010, 17(2):215-220.
36. Xiao Dakai., He Jianxing. Epithelial mesenchymal transition and lung cancer. J. Thorac. Dis. 2010, 2(3):154-159.